Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-09-15

FDA Approved: MIRTAZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic version of mirtazapine by Mylan Pharmaceuticals, confirming continued approval for major depressive disord…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

SUPPL AP for MIRTAZAPINE (MIRTAZAPINE)